AllPennyStocks.com Moderna’s stock doubles on promising cancer-vaccine results
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Other Penny Stock Movers

Sub-Dollar Cancer Diagnostics Play Erupts on Q2 Revenue
Target Expansion and Geophysics Survey Trigger 18% Surge for Norwegian Base-Metal Project
BC Copper Explorer Hits Native Copper and Potassic Alteration in Phase II Drilling
Most Popular
{{ index + 1 }}


Back to Top